Autologous Bone Marrow Concentration for Rotator Cuff Tear
The Effect of Autologous Bone Marrow Concentration Combined With Arthroscopy for Rotator Cuff Tear
Sponsor: Aeon Biotechnology Corporation
This observational or N/A phase trial investigates Bone Marrow and Rotator Cuff Tear and is currently ongoing. Aeon Biotechnology Corporation leads this study, which shows 7 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Sep 2024 — Sep 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
May 2022 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2021 — May 2022 [monthly]
Recruiting
▶ Show 2 earlier versions
-
May 2020 — Jan 2021 [monthly]
Recruiting
-
Feb 2019 — May 2020 [monthly]
Recruiting
First recorded
May 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Aeon Biotechnology Corporation
- Pei-Yuan Lee, MD
For direct contact, visit the study record on ClinicalTrials.gov .